HR 2345 · 109th Congress 2005–2007, ended

Tim Fagan's Law

Latest action · May 23, 2005 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 12, 2005
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Tim Fagan's Law or the Counterfeit Drug Enforcement Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to establish a criminal fine and/or imprisonment for a person who: (1) knowingly causes a prescription drug to be adulterated, misbranded, or misrepresented as an approved prescription drug and sells or trades the drug; or (2) purchases or trades for such drug knowing or having reason to know that the drug was knowingly adulterated, misbranded, or misrepresented. Requires a manufacturer of a drug to notify the Secretary of Health and Human Services within 48 hours after first receiving or becoming aware of information that reasonably suggests that such a violation may have occurred.

Deems a drug to be misbranded if it is not manufactured in accordance with the use of technologies that the Secretary determines are technically feasible and will assist in preventing such violations.

Requires the Secretary to establish alternative requirements to the extent that such requirements provide greater certainty on the chain of custody and are technically feasible.

Increases funding for Food and Drug Administration (FDA) inspections, examinations, and investigations.

Requires the Secretary to educate the public and health care professionals on counterfeit drugs.

Directs the Secretary: (1) upon a finding of reasonable probability that a drug intended for human use would cause serious health consequences or death, to issue an order requiring the appropriate person (including the manufacturers, importers, distributors, or retailers of the drug) to cease distribution of the drug and to notify and instruct health professionals to cease administering or prescribing the drug; and (2) amend the order to include a recall if necessary.

Cosponsors 14

Members who signed on, in the order they did. Signatures ran from Dec 13, 2005 to Jul 26, 2006.

SeatCosponsorSigned on
D-ILDanny K. DavisDec 13, 2005
D-CADiane E. WatsonDec 13, 2005
D-DCEleanor Holmes NortonDec 13, 2005
D-MDElijah E. CummingsDec 13, 2005
D-NYGary L. AckermanDec 13, 2005
D-NYMajor R. OwensDec 13, 2005
D-TXSheila Jackson LeeDec 13, 2005
D-NYBrian HigginsDec 14, 2005
D-AZEd PastorDec 22, 2005
D-CAHenry A. WaxmanDec 22, 2005
D-PAChaka FattahFeb 14, 2006
D-CALynn C. WoolseyFeb 14, 2006
D-MIJohn Conyers, Jr.Mar 2, 2006
D-NYNita M. LoweyJul 26, 2006

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 12, 2005
Health Subcommittee
Referred May 23, 2005

Actions 4

Everything that happened, newest first.

  1. May 23, 2005Referred to the Subcommittee on Health.
  2. May 12, 2005Introduced in House
  3. May 12, 2005Sponsor introductory remarks on measure. (CR E950-951)
  4. May 12, 2005Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
ExtensionsDebate and remarks E950Steve Israel D-NYMay 12, 2005

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 109-194SICK CRIME: COUNTERFEIT DRUGS IN THE UNITED STATES158 pagesOversight and Government Reform CommitteeNov 1, 2005
S. Hrg. 109-91FEDERAL RECOGNITION294 pagesIndian Affairs CommitteeMay 11, 2005

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 1396Counterfeit Drug Enforcement ActRelated billMar 22, 2005
S 1978Tim Fagan's LawRelated billNov 9, 2005

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes.
Short Titles as Introduced
Tim Fagan's Law
Counterfeit Drug Enforcement Act of 2005

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 12, 2005Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.